New model aims to predict jaw bone disease before it strikes

NCT ID NCT07691892

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study is developing a way to predict who might develop a serious jaw bone condition called medication-related osteonecrosis of the jaw (MRONJ) after dental procedures. Researchers are following adults who have taken bone-strengthening drugs like bisphosphonates or denosumab for at least two years and are scheduled for invasive dental work. By combining clinical exams, imaging, and biological samples like saliva and blood, they hope to build a risk prediction model that could help prevent this painful complication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a tool that helps dentists and doctors identify patients at high risk of jaw bone damage before oral procedures, allowing for better preventive care.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The prediction model may not be accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.